2018
DOI: 10.1016/j.celrep.2018.10.081
|View full text |Cite
|
Sign up to set email alerts
|

Computational Design of Epitope-Specific Functional Antibodies

Abstract: Highlights d ''Re-epitoping'' of an existing antibody by in silico design d Engineering a functional antibody to IL-17A d Crystal structure of the antibody-antigen complex confirms the targeted epitope

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
66
0
1

Year Published

2019
2019
2022
2022

Publication Types

Select...
3
3
3

Relationship

0
9

Authors

Journals

citations
Cited by 66 publications
(73 citation statements)
references
References 52 publications
1
66
0
1
Order By: Relevance
“…Recent reports have, however, provided preliminary evidence for the potential predictability of antibody-antigen interaction: (i) The antibody repertoire field has now established that antibody sequence diversity underlies predictable rules (Elhanati et al, 2015;Greiff et al, 2017bGreiff et al, , 2017a. (ii) The presence of transferable "specificity units" between distinct antibody molecules was recently suggested by showing that tightly binding functional antibodies may be conceived by designing and improving seemingly unrelated paratopes (Nimrod et al, 2018).…”
Section: Introductionmentioning
confidence: 99%
“…Recent reports have, however, provided preliminary evidence for the potential predictability of antibody-antigen interaction: (i) The antibody repertoire field has now established that antibody sequence diversity underlies predictable rules (Elhanati et al, 2015;Greiff et al, 2017bGreiff et al, , 2017a. (ii) The presence of transferable "specificity units" between distinct antibody molecules was recently suggested by showing that tightly binding functional antibodies may be conceived by designing and improving seemingly unrelated paratopes (Nimrod et al, 2018).…”
Section: Introductionmentioning
confidence: 99%
“…In biotherapeutics, DL algorithms are, for example, being trained on patient data to predict neoantigens in an effort to better inform immunotherapeutic development [35]. Moreover, computational design and prediction of antibody epitopes is also helping design novel antibodies [36], illustrating how biotherapeutic design is also benefiting from Big Data and AI.…”
Section: Drug Designmentioning
confidence: 99%
“…To date, as the ability to describe the antibody through binding affinity to the antigen is supplemented by information on antibody structure and amino acid sequences, several computational tools have been developed for the design of antibodies [17,[24][25][26][27]. For example, Rosetta Antibody is a novel antibody FV (the variable fragment critical for Ag binding) region structure prediction server [24].…”
Section: Introductionmentioning
confidence: 99%